Ignite Creation Date:
2025-12-24 @ 7:48 PM
Ignite Modification Date:
2025-12-28 @ 9:13 PM
Study NCT ID:
NCT05368103
Status:
COMPLETED
Last Update Posted:
2025-01-07
First Post:
2022-04-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of DAXDILIMAB for the Treatment of Moderate-to-Severe Alopecia Areata
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-27
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-26
Completion Date Type:
ACTUAL
First Submit Date:
2022-04-11
First Submit QC Date:
None
Study First Post Date:
2022-05-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-12-12
Results First Submit QC Date:
None
Results First Post Date:
2025-01-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-12
Last Update Post Date:
2025-01-07
Last Update Post Date Type:
ACTUAL